Methimazole prevents stress and chemical induced gastropathy in rats

Experimental and Toxicologic Pathology

Volumn 55, Issue 4, 2003, Pages 277-285

  Al Moutaery, Ahmed ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Antioxidant; Gastric secretion; Methimazole; Myeloperoxidase; Sulfhydryl; Ulcers

Indexed keywords

ALCOHOL; INDOMETACIN; MYELOPEROXIDASE; THIAMAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; STOMACH ACID SECRETION; STOMACH MUCUS; STOMACH PROTECTION; STOMACH ULCER; STRESS ULCER;

ANIMALIA;

EID: 0348108077     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1078/0940-2993-00325     Document Type: Conference Paper

References (75)

1. AL MOUTAERY AR, TARIQ M: Effect of vitamin E and selenium on hypothermic restraint stress and chemically induced ulcers. Dig Dis Sci 1996; 41: 1165-171.
2. ALLEN A: Structure of gastrointestinal mucus glycoproteins and the viscous and gel-forming properties of mucus. Br Med Bull 1978; 34: 28-33.
3. ALLEN A, SELLERS LA, BENNETT MK: The gastric mucosal epithelial barrier: Role of mucus and fibrin. Scand J Gastroenterol 1987; 20: 1191-1196.
4. 2 synthesis in vascular smooth muscle. Prostaglandins 1977; 14: 607-609.
5. BALEZS C, KISS E, LEOVEY A, et al.: The immunosuppressive effect of MMI on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clin Endocrinol Oxf 1986; 25: 7-16.
6. BELL AE, SELLERS LA, ALLEN A, et al.: Properties of gastric and duodenal mucus: Effects of proteolysis, disulfide reduction, bile, acid, ethanol and hypertonicity on mucus gel structure. Gastroenterology 1985; 88: 269-280.
7. BHARGAVA KP, GUPTA MB, TANGRI KK: Mechanism of ulcerogenic activity of indomethacin and ocyphenbutazone. Eur J Pharmacol 1973; 22: 191-195.
8. BOYD SC, SASAME HA, BOYD MR: Gastric glutathione depletion and acute ulcerogenesis by diethylmaleate given subcutaneously to rats. Life Sci 1981; 28: 2987-2992.
9. BRADLEY PP, PRIEBAT DA, CHRISTENSEN RD, et al.: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-209.
10. BRAUNLICH H, APPENROTH D, FLECK C: Protective effects of MMI against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol 1996; 17: 41-45.
11. 2-receptor antagonist. J Int Med Res 1975; 3: 86-92.
12. CORNE SJ, MORRISEY SM, WOODS RJ: A method for the quantitative estimation of gastric barrier mucus. J Physiol (London) 1974; 242: 116-117.
13. DELBECCARO EJ, ROBSON MC, HEGGERS JP, et al.: The use of specific thromboxane inhibitors to preserve the dermal microcirculation after burning. Surgery 1980; 87: 137-141.
14. DOERGE DR, DIVI RL: Porphyrin pi-cation and protein radicals in peroxidase catalysis and inhibition by antithyroid chemicals. Xenobiotica 1995; 25: 761-777.
15. EL DALY ES: Effect of MMI and fish oil treatment on gentamicin nephrotoxicity in rats. J Pharm Belg 1997; 52: 149-156.
16. ELFARRA AA, DUESCHER RJ, SAUSEN PJ, et al.: MMI protection of rats against gentamicin-induced nephrotoxicity. Can J Physiol Pharmacol 1994; 72: 1238-1244.
17. ELSBACH P, WEISS J: Phagocytosis of bacteria and phospholipi degradation. Biochim Biophys Acta 1988; 947: 29-52.
18. GOA KL, MONK JP: ENPROTIL: A preliminary review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer diseases. Drugs 1987; 3: 539-559.
19. GRIFFIN M, RAY W, SCHAFFNER W: Nonsteroidal antiinflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988; 109: 359-363.
20. GUARDIA T, GUZMAN JA, PESTCHANKER MJ, et al.: Mucus synthesis and sulfhydryl groups in cytoprotection mediated by dehydroleucodine, a sequiterpene lactone. J Natl Prod 1994; 57: 507-509.
21. GUTH PH, KOZBUR X: Pathogenesis of gastric microcirculatory and mast cell changes in restraint stress. Am J Dig Dis 1968; 13: 530-535.
22. HAWKEY CJ: Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ 1990; 300: 278-284.
23. HERNANDEZ LA, GRISHAM MB, TWOHIGH B, et al.: Role of neutrophils in ischemia reperfusion induced microvasculars injury. Am J Physiol 1987; 253: 699-703.
24. HOMSANIT M, SRIUSSADAPORN S, VANNASAENG S, et al.: Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism. Clin Endocrinol 2001; 54: 385.
25. HUANG XR, CHUN HUI CW, CHEN YX, et al.: Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 2001; 121: 619-630.
26. HUNG CR: Low susceptibility of stress ulcer in diabetic rats: role of cholinergic gastric motility. Clin J Physiol 1998; 41: 151-159.
27. KAPUI Z, BOER K, ROZSA I, et al.: Investigations of indomethacin-induced ulcer in rats. Arzneimittelforschung 1993; 43: 767-771.
28. KASUYA Y, URUSHIADANI T, OKABE S: Effects of various drugs and vagotomy on indomethacin induced gastric ulcers in the rat. Jpn J Pharmacol 1979; 29: 670-673.
29. KITAHORA T, GUTH PH: Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 1987; 93f: 810-817.
30. KOVACS KA, FIEGLER M, NEMES J, et al.: Effects of TRH on gastric acid secretion: a model for human study. J Physiol Paris 1997; 91: 265-269.
31. LAINE L, WEINSTEIN WM: Histology of alcoholic haemorrhagic gastritis: a prospective evaluation. Gastroenterology 1998; 94: 1254-1264.
32. LEE M, ALDRED K, LEE E, et al.: Aspirin-induced acute gastric mucosal injury is a neutrophil-dependentd process in rats. Am J Physiol 1992; 263: 920-926.
33. LIPPMAN W: Inhibition of indomethacin induced gastric ulceration in the rat by perorally administered synthetic and natural prostaglandin analogues. Prostaglandins 1974; 7: 1-9.
34. 1 by the gastric mucosa of several species. J Physiol (Lond) 1978; 275: 4.
35. MONCADA S, VANCE JR: Unstable metabolites of arachidonic acid. Br. Med Bull 1978; 34: 129-135.
36. NACE CG, GENTER MB, SAYRE LM, et al.: Effect of MMI, an FMO substrate and competitive inhibitor, on the neurotoxicity of 3,3′ -iminodipropionitrile in male rats. Fundam Appl Toxicol 1997; 37: 131-140.
37. NATALE G, LAZZERI G, BLANDIZZI C, et al.: Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage. Toxicol Appl Pharmacol 2001; 174: 17-26.
38. NEEDLEMAN P, ROY M, FERRENDELLI JA, et al.: Application of imidazole as a selective inhibitor of thromboxane synthetase in human platelets. Proc Natl Acad Sci USA 1977; 74: 1716-1720.
39. NISHIDA A, AKUZAWA S, KOBAYASHI A, et al.: Pharmacological profile of YMO22, a potent and selective gastrin/cholecystokinin-B receptor antogonist. Jpn J Pharmacol 1993; 61: 194.
40. NISHIDA A, KINAE N, FURUKOWA F, et al.: Enhancing effects of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(3,4)furanone Mx on cell proliferation and lipid peroxidation in the rat gastric mucosa. Canc Lett 1994a; 14: 151-157.
41. NISHIDA A, TAKINAMI Y, YUKI H, et al.: YM022 {(R)-1-(2,3-dihydro-1-(2-methyl-phenacyl) -2-oxo-5-phenyl-1H-14-benzodiazepin-3-yl)-3-(3-methylphenyl)-urea}, a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric duodenal lesions in rats. J Pharmacol Exp Ther 1994b; 270: 1256-1261.
42. 2 and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion. Am J Surg 1989; 157: 562-565.
43. 4 inhibitors on the experimentally induced gastric lesions in the rat. Res Comm Chem Pathol Pharmacol 1987; 58: 15-25.
44. PATEL HM, SANTANI DD, GOSWAMI SG: Evaluation of the effects of nicorandil on experimentally induced gastric ulcers. Pharmacology 2001; 63: 154-159.
45. PENDLEY CE, FITZPATRICK LR, EWING RW, et al.: The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat. J Pharmacol Exp Ther 1992; 265: 1348-1354.
46. PESKAR BM, SEYBERTH HW, PESKAR BA: Synthesis and metabolism of prostaglandins by human gastric mucosa. In: Advances in Prostaglandins and Thromboxane Research, Vol 7. Raven Press, New York, 1980; 151-154.
47. ODASHIMA M, Otaka M, ITO S, et al.: Effects of cyclosporin A on water-immersion stress-induced gastric lesion and gastric secretion in rats. J Gastroenterol 2000; 35: 369-371.
48. OREN R, MAARAVI Y, KARANELI F, et al.: Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis. Aliment Pharmacol Ther 1997; 11: 341-345.
49. ROSS AD, DEY I, JANES N, et al.: Effect of antithyroid drugs on hydroxyl radical formation and α-1-proteinase inhibitor inactivation by neutrophils: therapeutic implications. J Pharmacol Exp Ther 1998; 285: 1233-1238.
50. SAUSEN PJ, ELFARRA AA, COOLEY AJ: MMI protection of rats against chemically induced kidney damage in vivo. J Pharmacol Exp Ther 1992; 260: 393-401.
51. SCHIANTARELLI P, CADEL S, FOLCO GC: Gastroprotective effects of morniflumate, an esterified anti-inflammatory drug. Arzneim Forsch 1984; 34: 885-890.
52. SEDLACK J, LINDSAY RH: Estimation of total, protein bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-195.
53. SHAY H, KUMAROV SA, FELS SA, et al.: A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945; 5: 43-61.
54. SHIMIZU N, WATANABE T, ARAKAWA T, et al.: Pentoxifylline accelerates gastric ulcer healing in rats: roles of tumor necrosis factor alpha and neutrophils during the early phase of ulcer healing. Digestion 2000; 61: 157-164.
55. SINGER DS, KOHN LD, ZINGER H, et al.: MMI prevents induction of experimental systemic lupus erythematosus in mice. J Immunol 1994; 153: 873-880.
56. SLOMIANY BL, PIASEK A, SAROSIEK J, et al.: The role of surface and intracellular mucus in gastric mucosal protection against hydrogen ion. Compositional differences. Scand J Gastroenterol 1985; 20: 1191-1196.
57. SON M, KIM HK, KIM WB, et al.: Protective effect of taurin on indomethacin-induced gastric mucosal injury. Adv Exp Med Biol 1996; 403: 147-155.
58. SZABO S, TRIER JS, FRANKEL PW: Sulfhydryl compounds may mediate gastric cytoprotection. Science 1981; 214: 200-202.
59. TAKAGI K, OKABE S, SAZIKI R: A new method of experimental chronic ulcers in rats. Jpn J Pharmacol 1969; 19: 418-426.
60. TAKEUCHI Y, KITANO S, BANDOH T, et al.: Acceleration of gastric ulcer healing by omeprazole in portal hypertensive rats. Is its action mediated by gastrin release and the stimulation of epithelial proliferation? Eur Surg Res 2003; 35: 75-80.
61. TARIQ M, PARMAR NS, AQEEL AM: Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats. J Pharmacol Exp Ther 1987; 241: 602-607.
62. TARIQ M: Gastric antiulcer and cytoprotective effect of vitamin E in rats. Res Commun Chem Pathol Pharmacol 1988; 60: 87-96.
63. TARIQ M, AQEEL AM: Gatric ulcer and cytoprotective effects of dipyridamole in rats. J Pharmacol Exp Ther 1990; 253: 946-949.
64. VALCAVI U, CAPONI R, BRAMBILLA A, et al.: Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bisnorprotanoic acid in experimental animals. Arzneim Forsch 1992; 32: 657-663.
65. WALLACE JL, WHITTLE BJR: Role of mucus in the repair of gastric epithelial damage in the rat. Gastroenterology 1986; 91: 603-611.
66. WALLACE JL, MCKNIGHT GW, KEENAN CM, et al.: Effect of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology 1990; 98: 1178-1186.
67. WALLACE JL: Non-steroid anti-inflammatory drug gastropathy and cytoprotection: Pathogenesis and mechanisms re-examined. Scand J Gastroenterol Suppl 1992; 192: 3-8.
68. WANG J, GRIGGS ND, TUNG KS, et al.: Dynamic regulation of gastric autoimmunity by thyroid hormone. Int Immunol 1998; 10: 231-236.
69. WATANABE K: Some pharmacological factors involved in formation and prevention of stress ulcers in rats. Chem Pharm Bull 1966; 14: 101-107.
70. WATANABE T, ARAKAWA T, TOMINAGA K, et al.: Neutrophil accumulation in development of gastric ulcer induced by submucosal ingestion of endothelin-1 in rats. Dig Dis Sci 2000; 45: 880-888.
71. WEETMAN AP, TANDON N, MORGAN BP: Antithyroid drugs and release of inflammatory mediators by complement attacked thyroid cells. Lancet 1992; 340: 633-636.
72. YAMAMOTO S, KANEKO H, KONAGAWA T, et al.: Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori positive peptic ulcer patients. Helicobacter 2001; 6: 136-145.
73. YOKOTA T, OHAMI H, OHISHI H, et al.: Repression of acute gastric mucosal lesions by antioxidant-containing fraction from fermented products of okara (beancurd residue). J Nutr Sci Vitaminol Tokyo 1996; 42: 167-172.
74. YONETCI N, ORUC N, OZUTEMIZ AO, et al.: Effects of methimazole pretreatment on cerulein induced acutepancreatitis in rats. Exp Toxicol Pathol 2002; 54: 197-201.
75. YOUNES M, SIEGERS CP: Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem Biol Interact 1981; 34: 257-266.